Accurate cancer coding depends on what physicians document in the medical record. Without the right clinical details, coders are forced to assign unspecified codes like C34.90 instead of site-specific codes that properly reflect the patient's condition. This guide outlines the documentation elements oncology coders rely on to assign the most specific ICD-10-CM neoplasm code and satisfy risk adjustment requirements.
The Cancer Documentation Checklist
For every cancer encounter, the following elements should be documented to support accurate coding:
| Documentation Element | Why It Matters for Coding | Example |
|---|---|---|
| Anatomic site | Determines the C-code category | "Right upper lobe of lung" vs. "lung" |
| Laterality | Required for paired organs; avoids unspecified codes | "Left breast" = C50.912 vs. "breast" = C50.919 |
| Histologic type | Confirms malignancy and may affect code assignment | "Adenocarcinoma" vs. "squamous cell carcinoma" |
| Behavior | Distinguishes malignant, in situ, benign, uncertain | "Invasive ductal carcinoma" vs. "DCIS" |
| Primary vs. metastatic | Determines C00-C76 vs. C77-C79 assignment | "Primary lung, metastatic to bone" |
| Treatment status | Affects sequencing and Z-code assignment | "Currently on chemotherapy cycle 3 of 6" |
| TNM staging | Supports medical necessity and clinical context | "T2N1M0, Stage IIIA" |
Anatomic Site and Sub-Site Documentation
ICD-10-CM neoplasm codes are organized by anatomic site with increasing levels of specificity. The more detail the physician documents, the more specific the code assignment:
Lung Cancer Example
- "Lung cancer" → C34.90 (unspecified site, unspecified laterality)
- "Right lung cancer" → C34.91 (unspecified site, right)
- "Right upper lobe lung cancer" → C34.11 (upper lobe, right)
Prostate Cancer Example
- "Prostate cancer" → C61 (single code, no laterality needed)
- Document Gleason score, PSA level, and T-stage for clinical context
- Document metastatic sites separately (e.g., bone mets = C79.51)
Query Opportunity
When imaging reports specify "right upper lobe mass" but the physician note says only "lung cancer," send a query to align the documentation. This avoids using unspecified code C34.90 when C34.11 is supported.
Staging and Grading Documentation
While ICD-10-CM does not have stage-specific diagnosis codes for most cancers, staging documentation is critical for:
- Supporting medical necessity for treatment plans
- Justifying intensity of services (surgery, chemo, radiation)
- Meeting tumor registry and quality reporting requirements
- RADV audit defense when HCC codes are questioned
Key Staging Elements to Document
- Clinical stage (cTNM): Based on physical exam, imaging, and biopsy before definitive treatment
- Pathologic stage (pTNM): Based on surgical pathology after resection
- Grading: Gleason score (prostate), Bloom-Richardson (breast), FIGO (gynecologic)
- Biomarkers: ER/PR/HER2 (breast), EGFR/ALK (lung), KRAS (colorectal)
Treatment Status Documentation
Clear documentation of treatment status determines whether to assign an active neoplasm code (C-code), a Z-code for treatment encounter, or a history code (Z85.-):
| Documentation Language | Coding Implication |
|---|---|
| "Active lung cancer, on chemo" | C34.xx (active malignancy) + Z51.11 if encounter for chemo |
| "No evidence of disease, surveillance" | Z85.xx (personal history) + Z08 (surveillance encounter) |
| "Recurrent prostate cancer" | C61 (active malignancy, NOT Z85.46) |
| "Hormone therapy for prostate cancer" | C61 + Z79.899 (long-term use of other agents) |
Validate Cancer Codes Against ICD-10-CM Guidelines
Check neoplasm codes for gender conflicts, fiscal year validity, and proper sequencing.
Look up ICD 10 CM codes to find the correct neoplasm code before validation.
Documenting Metastatic Disease
When cancer has metastasized, documentation must clearly identify:
- Primary site: Where the cancer originated (even if excised)
- All secondary sites: Each metastatic location requires a separate C77-C79 code
- Direction of spread: "Metastatic TO bone" (C79.51) vs. "Metastatic FROM bone" (primary bone C40-C41)
Common Documentation Error
"Metastatic cancer" without specifying the primary and secondary sites creates ambiguity. Coders cannot determine if the documented site is the primary or the metastatic site without clear directional language.
Clear vs. Ambiguous Metastatic Documentation
- Clear: "Primary right upper lobe adenocarcinoma with metastasis to brain and liver"
- Ambiguous: "Metastatic lung cancer" (Is lung the primary or the metastatic site?)
- Clear: "History of colon cancer, now with liver metastases" (primary excised, secondary active)
Documenting Treatment Complications
Cancer treatment complications require specific documentation to assign the correct codes:
- Anemia due to chemotherapy: Document as "adverse effect of antineoplastic" → D64.81 + T45.1X5A
- Neutropenia due to chemo: D70.1 (Agranulocytosis secondary to cancer chemotherapy)
- Nausea/vomiting from chemo: Document as treatment-related, not disease-related
- Radiation dermatitis: L58.0-L58.9 depending on severity
Cancer Codes and Risk Adjustment
Many neoplasm codes map to HCC categories in the CMS-HCC risk adjustment model. Proper documentation ensures these diagnoses receive risk adjustment credit:
- Active malignancies must be documented and coded at each encounter for risk adjustment capture
- History codes (Z85.-) do NOT map to HCC categories
- Document ongoing treatment or monitoring to justify continued active code assignment
- Use MEAT criteria (Monitor, Evaluate, Assess, Treat) at each visit
For the complete coding rules, see our Neoplasm Coding Guidelines or explore the full ICD-10 coding guidelines. View commonly coded neoplasm codes in the ICD-10 Code Directory.